Wingard RL - Search Results

1

Increased energy expenditure in hemodialysis patients.

Ikizler TA, Wingard RL, Sun M, Harvell J, Parker RA, Hakim RM. Ikizler TA, et al. Among authors: wingard rl. J Am Soc Nephrol. 1996 Dec;7(12):2646-53. doi: 10.1681/ASN.V7122646. J Am Soc Nephrol. 1996. PMID: 8989743 Clinical Trial.

2

Extracorporeal treatment of familial hypercholesterolemia with monoclonal antibodies to low-density lipoprotein.

Wingard RL, Lee WO, Hakim RM. Wingard RL, et al. Am J Kidney Dis. 1991 Nov;18(5):559-65. doi: 10.1016/s0272-6386(12)80650-0. Am J Kidney Dis. 1991. PMID: 1951335

3

Extracorporeal removal of anti-HLA antibodies in transplant candidates.

Hakim RM, Milford E, Himmelfarb J, Wingard R, Lazarus JM, Watt RM. Hakim RM, et al. Am J Kidney Dis. 1990 Nov;16(5):423-31. doi: 10.1016/s0272-6386(12)80054-0. Am J Kidney Dis. 1990. PMID: 2239932 Clinical Trial.

4

Malnutrition in peritoneal dialysis patients: etiologic factors and treatment options.

Ikizler TA, Wingard RL, Hakim RM. Ikizler TA, et al. Among authors: wingard rl. Perit Dial Int. 1995;15(5 Suppl):S63-6. Perit Dial Int. 1995. PMID: 7578490 Review.

5

Interventions to treat malnutrition in dialysis patients: the role of the dose of dialysis, intradialytic parenteral nutrition, and growth hormone.

Ikizler TA, Wingard RL, Hakim RM. Ikizler TA, et al. Among authors: wingard rl. Am J Kidney Dis. 1995 Jul;26(1):256-65. doi: 10.1016/0272-6386(95)90181-7. Am J Kidney Dis. 1995. PMID: 7611260 Review.

6

Short-term effects of recombinant human growth hormone in CAPD patients.

Ikizler TA, Wingard RL, Breyer JA, Schulman G, Parker RA, Hakim RM. Ikizler TA, et al. Among authors: wingard rl. Kidney Int. 1994 Oct;46(4):1178-83. doi: 10.1038/ki.1994.382. Kidney Int. 1994. PMID: 7861714 Free article. Clinical Trial.

7

Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin.

Wingard RL, Parker RA, Ismail N, Hakim RM. Wingard RL, et al. Am J Kidney Dis. 1995 Mar;25(3):433-9. doi: 10.1016/0272-6386(95)90105-1. Am J Kidney Dis. 1995. PMID: 7872321 Clinical Trial.

8

Effect of the dialysis membrane in the treatment of patients with acute renal failure.

Hakim RM, Wingard RL, Parker RA. Hakim RM, et al. Among authors: wingard rl. N Engl J Med. 1994 Nov 17;331(20):1338-42. doi: 10.1056/NEJM199411173312003. N Engl J Med. 1994. PMID: 7935703 Free article. Clinical Trial.

9

The effects of recombinant human growth hormone and intradialytic parenteral nutrition in malnourished hemodialysis patients.

Schulman G, Wingard RL, Hutchison RL, Lawrence P, Hakim RM. Schulman G, et al. Among authors: wingard rl. Am J Kidney Dis. 1993 May;21(5):527-34. doi: 10.1016/s0272-6386(12)80399-4. Am J Kidney Dis. 1993. PMID: 8488821 Clinical Trial.

10

Spontaneous dietary protein intake during progression of chronic renal failure.

Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM. Ikizler TA, et al. Among authors: wingard rl. J Am Soc Nephrol. 1995 Nov;6(5):1386-91. doi: 10.1681/ASN.V651386. J Am Soc Nephrol. 1995. PMID: 8589313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters